US.ELV · Elevance Health

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.314960078538418,
        "turnoverUsdM": 344.96605207299996,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.ELV",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 368.5386,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 2.5,
        "macd_score": 1,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 4.6,
      "take_profit_price": 405.7515,
      "target_multiplier": 1.9,
      "technical_strength": 1.65,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.629920157076836,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 50.3,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 47.3,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 3
  },
  "market": {
    "ma20": 403.5015,
    "ma50": 397.2188,
    "close": 386.43,
    "prevClose": 381.67,
    "avgVolume20": 1252645,
    "volumeRatio": 0.71,
    "changePercent": 1.25
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 3,
    "details": {
      "ret_5d": -0.024388411970899693,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 3,
      "vcp_bonus": 0,
      "vol_ratio": 0.7033010320649177,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.778871483656668,
      "volat_points": 0,
      "day_range_pct": 0.01912382369701688,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 50.3,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.8,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 76,
        "contribution": 3.8
      },
      {
        "raw": 5.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 26,
        "contribution": 5.2
      },
      {
        "raw": 10.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 68,
        "contribution": 10.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 12.7,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 42.33,
        "contribution": 12.7
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 47.3,
    "details": [
      "基本面分析總分: 3.8/5分",
      "資金流分析總分: 5.2/20分",
      "市場環境分析總分: 10.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 12.7/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.8,
      "資金流": 5.2,
      "市場環境": 10.2,
      "情緒分析": 6,
      "技術信號": 12.7,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.5,
          "epsPoints": 0,
          "roePoints": 0.4,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 344.96605207299996,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.ELV",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 16.39
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 727.77950075,
                "ma50": 716.81699944,
                "name": "QQQ",
                "close": 749.58002,
                "points": 2
              },
              "spy": {
                "ma20": 764.8284993999999,
                "ma50": 763.70219804,
                "name": "SPY",
                "close": 769.64001,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.314960078538418,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142588593,
                "url": "https://finnhub.io/api/news?id=4405a8ec976a6394896c433c22b18146435a3e22796806bc702d41c459103434",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1790944804,
                "headline": "Are Medical Stocks Lagging  Elevance Health, Inc. (ELV) This Year?"
              },
              {
                "id": 142559915,
                "url": "https://finnhub.io/api/news?id=5b1f8482a4a75f4afceee20676594717d7f361c8202c392ef8f65b3d9eff68ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Cambiar Opportunity Fund, managed by Cambiar Investors, published its Q2 2026 investor letter. The letter can be downloaded here. U.S. equity markets experienced a significant rebound in Q2, with the S&P 500 rising 15.2% and the Russell 2000 up 21.5%. Growth stocks outperformed value, although value retained a year-to-date lead. The market’s rise was fueled […]",
                "category": "company",
                "datetime": 1790869389,
                "headline": "Elevance Health (ELV): Conviction Pays Off as Underwriting Disciplines Stabilize Margins"
              },
              {
                "id": 142283253,
                "url": "https://finnhub.io/api/news?id=1cc4e9e60148bf122a4635cc45b874c8d51d8019695f722e1d3607154f9eac2c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health has delivered a 1 year gain that puts the stock firmly on investors' radar, and the latest reaffirmed earnings outlook has only sharpened the focus on what you are paying for each dollar of profit. With the price around US$410.95 at the last close, the key issue now is whether that tag lines up with the insurer's earnings power. The stock is up 33.6% over the past year, which raises the question of whether that move is grounded in its underlying earnings profile. Management...",
                "category": "company",
                "datetime": 1789884728,
                "headline": "Elevance Health (ELV) Stock May Be Below Fair Value As Guidance Was Reaffirmed"
              },
              {
                "id": 142165895,
                "url": "https://finnhub.io/api/news?id=4e306319d28b9c86fab6c2c9dd4c4556d7f2825f07cdf375061043fa75828a64",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "ELV vs. DHR: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1789486803,
                "headline": "ELV or DHR: Which Is the Better Value Stock Right Now?"
              },
              {
                "id": 141950829,
                "url": "https://finnhub.io/api/news?id=0d6a03820241bbbe5b1f009058d13066016bbfb4577f67b0d52a1150f1e424ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1788876918,
                "headline": "2 Reasons to Watch ELV and 1 to Stay Cautious"
              },
              {
                "id": 141446869,
                "url": "https://finnhub.io/api/news?id=f83be2ff10be414db328b84762aa96c3abb7549d3caafc3d998c02964c8ed095",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...",
                "category": "company",
                "datetime": 1788541717,
                "headline": "Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run"
              }
            ],
            "raw_source": [
              {
                "id": 142588593,
                "url": "https://finnhub.io/api/news?id=4405a8ec976a6394896c433c22b18146435a3e22796806bc702d41c459103434",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1790944804,
                "headline": "Are Medical Stocks Lagging  Elevance Health, Inc. (ELV) This Year?"
              },
              {
                "id": 142581267,
                "url": "https://finnhub.io/api/news?id=8c783d54f798f8baba878d1a33d3bd74c4603a700c35efe48cef11b208f1c6a7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CVS Health (CVS) stock lost 12.7% in the past month without company news, and peers UnitedHealth, Cigna and Elevance Health fell too. The S&P 500 rose 0.6% over the same month. The shares now trade 22.5% below their 52-week high. How much further could CVS stock fall if the market itself turns down.",
                "category": "company",
                "datetime": 1790929464,
                "headline": "How Much Downside Is Left In CVS Health Stock?"
              },
              {
                "id": 142559915,
                "url": "https://finnhub.io/api/news?id=5b1f8482a4a75f4afceee20676594717d7f361c8202c392ef8f65b3d9eff68ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Cambiar Opportunity Fund, managed by Cambiar Investors, published its Q2 2026 investor letter. The letter can be downloaded here. U.S. equity markets experienced a significant rebound in Q2, with the S&P 500 rising 15.2% and the Russell 2000 up 21.5%. Growth stocks outperformed value, although value retained a year-to-date lead. The market’s rise was fueled […]",
                "category": "company",
                "datetime": 1790869389,
                "headline": "Elevance Health (ELV): Conviction Pays Off as Underwriting Disciplines Stabilize Margins"
              },
              {
                "id": 142556252,
                "url": "https://finnhub.io/api/news?id=62dd4382ceb69a7deaca256429946010e98111a21c72c1059336af7febef8d52",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "INDIANAPOLIS, October 01, 2026--Elevance Health (NYSE: ELV) announced today that its affiliated health plans will offer 2027 Medicare Advantage plans designed to help members navigate healthcare more confidently through meaningful choice, simpler benefit experiences and personalized support that reflects individual health needs.",
                "category": "company",
                "datetime": 1790852400,
                "headline": "Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support"
              },
              {
                "id": 142523045,
                "url": "https://finnhub.io/api/news?id=a156c7cdf57b21bcc560e53a1e5b96b470eccb98af96b49b442a3e5860632e18",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The insurer said it’s trying to restrict hospitals from charging higher rates for services at off-campus outpatient departments. Hospital groups say the reimbursement cuts could threaten access to care.",
                "category": "company",
                "datetime": 1790793540,
                "headline": "Elevance cracks down on hospital billing for off-campus care"
              },
              {
                "id": 142524167,
                "url": "https://finnhub.io/api/news?id=798ed82e90d79cc9ef140a180982e384d1ba51a4baf8f035b5a42fdf12324ab1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health is scheduled to report its third-quarter results soon, and analysts expect a double-digit earnings decline.",
                "category": "company",
                "datetime": 1790781948,
                "headline": "Elevance Health's Quarterly Earnings Preview: What You Need to Know"
              },
              {
                "id": 142500417,
                "url": "https://finnhub.io/api/news?id=235745f2ec56182ee07c85a38d1c9a880f6d5ddce34e70ce68a6175f09891376",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth (UNH) stock trades at 22.5 times its past year's adjusted earnings, which are normalized net income with stock-based pay added back. That multiple leaves little room for error after three years of shrinking operating margins, sitting near the stock's 10-year median despite fundamentally weaker profitability. But the price looks different against the profit expected for fiscal 2026 and fiscal 2027. So what are UnitedHealth investors betting on.",
                "category": "company",
                "datetime": 1790706345,
                "headline": "What Are UNH Stock Investors Betting On?"
              },
              {
                "id": 142498204,
                "url": "https://finnhub.io/api/news?id=1fadd9409892b197cf4a6a4a6d2ac7ceb70dc26e036272850d4db43f80d48aa9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Whether that something is enough to make UNH worth holding now depends on costs that management has not yet fully tamed.",
                "category": "company",
                "datetime": 1790690898,
                "headline": "UnitedHealth Stock Has Gone Nowhere for Five Years. Its Dividend Has Not"
              },
              {
                "id": 142445070,
                "url": "https://finnhub.io/api/news?id=baf528f100e1ef3465e778537c88f7af85008a24a49282b9dbc9af008aff8771",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "With traders bracing for another possible 0.25% Fed hike in October, solid labor data and firm inflation keep pressure on anything seen as risky. Defensive dividend stocks suddenly feel less boring and more like a potential anchor for a jumpier market, especially for investors who care about steady income when policy stays tight. This article breaks down three large cap dividend payers exposed to these macro shocks and explores how the latest data may help or hurt each stock. The three...",
                "category": "company",
                "datetime": 1790485930,
                "headline": "3 U.S. Dividend Stocks Offering Defensive Income as Fed Rate Pressure Persists"
              },
              {
                "id": 142384683,
                "url": "https://finnhub.io/api/news?id=c21395e30aacf5f3bd20fbf13e9006f0d6a4e0d20793588da316f5b79e250925",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "If you own CVS Health (CVS), the primary focus shifts from 2026 execution toward potential headwind variables heading into 2027. Management raised its 2026 earnings outlook on its fiscal Q2 2026 call in August. It also gave an early read on 2027, a quarter sooner than usual. One warning in that read came with no number. Over the past three months, the shares lost 15.2%, while the S&P 500 gained 5.0%. What is the 2027 problem CVS would not put a number on.",
                "category": "company",
                "datetime": 1790267681,
                "headline": "What Should CVS Stock Investors Be Watching Now?"
              },
              {
                "id": 142365220,
                "url": "https://finnhub.io/api/news?id=dd32755ec590d1799b7d5ec3ad6f92a43dd03c670e0a73958df4dc85ca5cfada",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "By Exec Edge Editorial Staff Health insurance premiums have climbed for years. Deductibles have climbed right along with them. Yet a growing number of American households are choosing neither, opting instead for a decades-old alternative, which is not health insurance, built around monthly contributions and community values. “People are clearly paying high premiums now,” Liberty […] The post Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Pod",
                "category": "company",
                "datetime": 1790197600,
                "headline": "Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Podcast"
              },
              {
                "id": 142363187,
                "url": "https://finnhub.io/api/news?id=b94d47bbce0ea7953955a6a923c93c2c6a1272c92b020e9b95530b838666b05c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth Group (UNH) stock has risen about 40% since late March 2026, against close to 19% for the S&P 500. Read cold, that looks like a recovery nobody could have timed. It was not hidden. The company had said plainly, months before the shares turned, that it would give up members to rebuild margin.",
                "category": "company",
                "datetime": 1790180809,
                "headline": "Did UnitedHealth Name The Fix Before Its Stock Ran?"
              },
              {
                "id": 142342070,
                "url": "https://finnhub.io/api/news?id=34b69edf2a74f0cb424507a082f3bdd474474b0b9314bc154e1fc4d76ca78ba1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth (UNH) has turned its profits around. Operating earnings rose 55% in the second quarter of 2026, and management raised its full-year adjusted earnings guide to $19.50 to $20 a share. Revenue, though, has nearly stopped growing. So the rest of the recovery rests on something the company only partly controls: the medical bills of the people it insures.",
                "category": "company",
                "datetime": 1790100599,
                "headline": "Can UNH Stock Keep Growing Earnings While Its Sales Stall?"
              },
              {
                "id": 142335517,
                "url": "https://finnhub.io/api/news?id=525f8ce75b2d2134a94e42a0b8d98c14e755d06e527b5254fc4df10cecf195a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Centene's robust cash flow is helping cut debt, with a lower debt-to-capital ratio and added liquidity reshaping its balance sheet.",
                "category": "company",
                "datetime": 1790074860,
                "headline": "How Centene's Strong Cash Flow Is Reshaping Its Balance Sheet"
              },
              {
                "id": 142337363,
                "url": "https://finnhub.io/api/news?id=5d802c08b9bd61484af6cee60a2b695e684a6d472eed50aa455ec649f1d025a6",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "https://www.wsj.com/politics/policy/vance-led-task-force-set-to-remove-760-000-allegedly-fraudulent-obamacare-enrollments-0fbb72d7",
                "category": "company",
                "datetime": 1790068232,
                "headline": "'Vance-Led Task Force Set to Remove 760,000 Allegedly Fraudulent Obamacare Enrollments' - WSJ Exclusive"
              },
              {
                "id": 142294889,
                "url": "https://finnhub.io/api/news?id=7cb8d912d7f4307bf0bc36e40cb4309796874675baa460e3d9bc3076acc5d41d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155443326/image_155443326.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Harris Associates' 13F portfolio rose to $75.42B in Q2 2026, with 30 core positions exceeding 1.25% each. Read more on the portfolio here.",
                "category": "company",
                "datetime": 1789937428,
                "headline": "Tracking William Nygren's Harris Associates Portfolio - Q2 2026 Update"
              },
              {
                "id": 142283253,
                "url": "https://finnhub.io/api/news?id=1cc4e9e60148bf122a4635cc45b874c8d51d8019695f722e1d3607154f9eac2c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health has delivered a 1 year gain that puts the stock firmly on investors' radar, and the latest reaffirmed earnings outlook has only sharpened the focus on what you are paying for each dollar of profit. With the price around US$410.95 at the last close, the key issue now is whether that tag lines up with the insurer's earnings power. The stock is up 33.6% over the past year, which raises the question of whether that move is grounded in its underlying earnings profile. Management...",
                "category": "company",
                "datetime": 1789884728,
                "headline": "Elevance Health (ELV) Stock May Be Below Fair Value As Guidance Was Reaffirmed"
              },
              {
                "id": 142261918,
                "url": "https://finnhub.io/api/news?id=46fedd06c559ba8b3d63e97060c25dad3687b4ac45e0e46d0a2425c82202bb5e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Track weekly dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend dates and pay dates here.",
                "category": "company",
                "datetime": 1789755255,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week September 20"
              },
              {
                "id": 142253967,
                "url": "https://finnhub.io/api/news?id=cc96e85bcbd3f911ee04bc5faedce46fa69ce08f2304cc6523cc0ba700260543",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.",
                "category": "company",
                "datetime": 1789733701,
                "headline": "Should You Buy CVS Stock For The Margin Aetna Is Rebuilding?"
              },
              {
                "id": 142243261,
                "url": "https://finnhub.io/api/news?id=97da61e50488ab738935ec0c987e2d2f0bf7f71c8c70942a1e69ff508905292d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.",
                "category": "company",
                "datetime": 1789715600,
                "headline": "2 Surging  Stocks on Our Watchlist and 1 We Brush Off"
              },
              {
                "id": 142198233,
                "url": "https://finnhub.io/api/news?id=62893c934108390cb4e84f708579862ec5e7b3b4291db08db0f2465e4946203f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.",
                "category": "company",
                "datetime": 1789579013,
                "headline": "The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet"
              },
              {
                "id": 142194544,
                "url": "https://finnhub.io/api/news?id=fce05d1042311f51521afde0637491e147e66c86aae7741630cbd8ba237fa8a2",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2260474979/image_2260474979.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "During the quarter, we added 8 new positions and exited 6 positions, bringing the number of positions in the Fund to 43.",
                "category": "company",
                "datetime": 1789548840,
                "headline": "Baron Health Care Fund Q2 2026 Portfolio Activity"
              },
              {
                "id": 142165895,
                "url": "https://finnhub.io/api/news?id=4e306319d28b9c86fab6c2c9dd4c4556d7f2825f07cdf375061043fa75828a64",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "ELV vs. DHR: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1789486803,
                "headline": "ELV or DHR: Which Is the Better Value Stock Right Now?"
              },
              {
                "id": 142165607,
                "url": "https://finnhub.io/api/news?id=81c3d116e6c3b7c554af98f977c4bc6cd338554110e0abca84fed3a196ba0a12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CVS Health's Health Services arm is gaining from pharmacy strength and improving care delivery, with robust new sales and clinic economics supporting growth.",
                "category": "company",
                "datetime": 1789481700,
                "headline": "Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth"
              },
              {
                "id": 142141425,
                "url": "https://finnhub.io/api/news?id=1319d644a68d1a16e7a0fdb153103e0f98cb9c4ea9eee6a94f946c434dcaf49d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.",
                "category": "company",
                "datetime": 1789420257,
                "headline": "CVS Stock Returned $24B In Cash: Why Did It Still Lag The Market?"
              },
              {
                "id": 142141467,
                "url": "https://finnhub.io/api/news?id=40c7ec190f17456e6d4cedac5eaa7a53021f0b8cfbc64b185ac0b994c06ac9e3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth (UNH) has spent the past year repairing margins rather than chasing growth. The shares rebounded well ahead of any actual margin recovery: up about 38% over the past six months, though down about 6% over the past three, and still behind the S&P 500 over the past twelve months, 12.2% for the stock against 18.6% for the index. What argues for owning them now shows up in cash running ahead of reported profit.",
                "category": "company",
                "datetime": 1789414884,
                "headline": "Should You Buy UNH Stock Because Its Cash Runs Ahead Of Its Profit?"
              },
              {
                "id": 142095118,
                "url": "https://finnhub.io/api/news?id=741d6ea90e0aa04dbe0d39d21eb4f839bf1c5579d7b3969b84086379cdb5c707",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.",
                "category": "company",
                "datetime": 1789177145,
                "headline": "3 Profitable Stocks to Keep an Eye On"
              },
              {
                "id": 142088283,
                "url": "https://finnhub.io/api/news?id=8005a02c755811a9a0a209f2f5677afb24b48c9bf148a5123db5ea187fd45728",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CNC is set to reshape its Medicare Advantage business around dual-eligible members and a simpler footprint to drive margin recovery.",
                "category": "company",
                "datetime": 1789143420,
                "headline": "Can Centene's Medicare Advantage Strategy Unlock Better Margins?"
              },
              {
                "id": 142141590,
                "url": "https://finnhub.io/api/news?id=6f50b5fe50de9fb6fcc234af99e7fa929b8bff2e5a1b149a55e571d323dcebee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Key Takeaways:Guidance Raised: Elevance Health lifted 2026 adjusted EPS guidance to at least $27, up from prior levels, after a strong Q2. Price Projection: Based on current execution, ELV stock could reach $494 by December 2028.",
                "category": "company",
                "datetime": 1789133912,
                "headline": "Up 36% in the Last 12 Months, Does Elevance Health Stock Have More Room to Run Through 2028?"
              },
              {
                "id": 142064801,
                "url": "https://finnhub.io/api/news?id=986a6117d59e8175d3255bd7bd52028ee01dd339371ca80d62205c5bea18363a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.",
                "category": "company",
                "datetime": 1789069012,
                "headline": "Should You Buy Elevance Health Stock For The Margin It Lost?"
              },
              {
                "id": 142064393,
                "url": "https://finnhub.io/api/news?id=7c28e78d9040a5cce97fe2b77384836940d53d535f5f71724541cccc657ad8ee",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "ELV",
                "summary": "Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1789067101,
                "headline": "Thursday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 142063328,
                "url": "https://finnhub.io/api/news?id=0ddaecaced7b45415c54683e8f459cfc0dd0f482dcb3ec10e83497f59326cbf3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.",
                "category": "company",
                "datetime": 1789061100,
                "headline": "UnitedHealth Reshapes Florida WellMed Operations With TPG Deal"
              },
              {
                "id": 142062620,
                "url": "https://finnhub.io/api/news?id=42d1713943407a8373594164c6027ae51524d6e82d99ced0e1abd43763cbc25b",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "ELV",
                "summary": "Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1789058101,
                "headline": "What's going on in today's session: S&P500 movers"
              },
              {
                "id": 142064037,
                "url": "https://finnhub.io/api/news?id=57d493ab3351dc74de676b0cd87b6e9bd1621b6634e7636031016eeb9aed01a9",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/10/Market--Down--Creative-Crash-Recession-C.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Crude jumped 6% and 30-year Treasury yields hit levels last seen in 2007 as a hot PPI print pushed Fed rate-hike odds toward 70% ahead of Friday's CPI.",
                "category": "company",
                "datetime": 1789050419,
                "headline": "Stock Market Today: Nasdaq 100 Tumbles as Oil Spikes 6%, Yields Hit 19-Year High"
              },
              {
                "id": 142066812,
                "url": "https://finnhub.io/api/news?id=c3a8490e26f351d1f1e73fe0cfa27c4a9c9d2378d030b2065497eda26ab93539",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/10/Elevance-Health-Photo-by-Jonathan-Weiss-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health shares are jumping Thursday after the company reaffirmed its FY26 earnings guidance ahead of a series of investor meetings.",
                "category": "company",
                "datetime": 1789049583,
                "headline": "Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation"
              },
              {
                "id": 142060147,
                "url": "https://finnhub.io/api/news?id=10663dfaeed0ebff97aaefb390f63748c5ff769ad0026a71593c7860874b7688",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health Inc (NYSE:ELV) recently announced a total dividend of $1.72 per share, with the ex-dividend date set for 2026-09-10.  For investors, the ex-dividend date is a critical marker: shareholders must own the stock before this date to qualify for the upcoming payment.  As investors look forward to this next distribution, the spotlight also shines on the company's dividend history, yield, and growth rates.",
                "category": "company",
                "datetime": 1789038250,
                "headline": "Elevance Health Inc's Dividend Analysis"
              },
              {
                "id": 142066813,
                "url": "https://finnhub.io/api/news?id=75266bf8779312c3481306c942803f68b1d5d054daa55df5708350b7f3aa6de4",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $20.10 vs $20.26 Est..",
                "category": "company",
                "datetime": 1789021705,
                "headline": "Elevance Health Affirms FY2026  GAAP EPS expected to be more than $20.10 vs $20.26 Est"
              },
              {
                "id": 142066814,
                "url": "https://finnhub.io/api/news?id=c83bfcfa124b06b727e41e969f3edbdbe6c30d149d6bbfaf7d6627840dccba4e",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $27.00 vs $26.91 Est..",
                "category": "company",
                "datetime": 1789021680,
                "headline": "Elevance Health Affirms FY2026  Adj EPS expected to be more than $27.00 vs $26.91 Est"
              },
              {
                "id": 142028659,
                "url": "https://finnhub.io/api/news?id=0081c272b61c689e1879a429e5f7c5cd199146ca47c277f5122abab9309cdee1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.",
                "category": "company",
                "datetime": 1788982210,
                "headline": "Why Is UNH Stock Trading At A Premium With The Slowest Growth?"
              },
              {
                "id": 142025949,
                "url": "https://finnhub.io/api/news?id=1e60277542dd68ec98f2ca5040753093f4e61bd880edcdf64de9408c92768f2e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.",
                "category": "company",
                "datetime": 1788964814,
                "headline": "UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation"
              },
              {
                "id": 141950829,
                "url": "https://finnhub.io/api/news?id=0d6a03820241bbbe5b1f009058d13066016bbfb4577f67b0d52a1150f1e424ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1788876918,
                "headline": "2 Reasons to Watch ELV and 1 to Stay Cautious"
              },
              {
                "id": 141546908,
                "url": "https://finnhub.io/api/news?id=8e571c6258a78e295e3d3b62ceae232f24f7212af2894b0de642b2676a6a05ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.",
                "category": "company",
                "datetime": 1788642735,
                "headline": "Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2."
              },
              {
                "id": 141485601,
                "url": "https://finnhub.io/api/news?id=a14fa2d71c991d1424c650e89ccc0365f647e29aec84a754bdf9a4133b2e0743",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Explore this week’s dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend and pay dates.",
                "category": "company",
                "datetime": 1788562641,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week September 6"
              },
              {
                "id": 141446869,
                "url": "https://finnhub.io/api/news?id=f83be2ff10be414db328b84762aa96c3abb7549d3caafc3d998c02964c8ed095",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...",
                "category": "company",
                "datetime": 1788541717,
                "headline": "Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run"
              },
              {
                "id": 141446662,
                "url": "https://finnhub.io/api/news?id=5d83f5780b6dfb902bdb5621ef012795ad52a453dd0b77ba71da028ec44295d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.",
                "category": "company",
                "datetime": 1788537840,
                "headline": "UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 6,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 45,
            "discarded_article_count": 39
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 12.7,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 0.6,
          "macdPoints": 0.8,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.6,
            "vcp_reason": "跌縮量(近10日3日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 0,
              "vol_ref": 1123233.3333333333,
              "down_days": 9,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 1248150,
              "avg_vol_20": 1269300,
              "avg_vol_30": 1123233.3333333333,
              "range_pct_10": 0.10252827426773996,
              "range_pct_20": 0.13309013619776255,
              "range_pct_30": 0.13309013619776255,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.1112116805650356,
              "dist_to_20d_high": 0.09537191058894798,
              "down_shrink_days": 3,
              "breakout_level_20d": 427.17001,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.7703671902130311
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 0.8,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.314960078538418,
              "turnoverUsdM": 344.96605207299996,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.ELV",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 368.5386,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 2.5,
              "macd_score": 1,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 4.6,
            "take_profit_price": 405.7515,
            "target_multiplier": 1.9,
            "technical_strength": 1.65,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.629920157076836,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 8.9457,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.31
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -128.79
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.2153
    },
    "kdj": {
      "d": 18.39,
      "j": 21.97,
      "k": 19.59,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 12.03
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": -5702200,
      "recentSlope": -858020,
      "previousSlope": -241420
    },
    "rsi": 12.73,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 407.357,
      "position": "SAR喺價上",
      "distancePct": 5.42,
      "previousTrend": "下降"
    },
    "ma50": 397.2188,
    "macd": {
      "macd": -3.9999773912687147,
      "trend": "看跌",
      "signal": -0.8772999320676144,
      "histogram": -3.1226774592011
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 405.154,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.71,
      "score": 2,
      "avgVolume": 1252645,
      "currentVolume": 892700
    },
    "derived": {
      "ma20": 403.5015,
      "ma50": 397.2188,
      "prevClose": 381.67,
      "avgVolume10": 1129960,
      "avgVolume20": 1252645,
      "changePercent": 1.25,
      "avgVolumeForScore": 1252645
    },
    "ma_cross": {
      "ma20": 403.5015,
      "ma50": 397.2188,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 404.919,
      "prevMa50": 397.0764,
      "spreadPct": 1.58,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 380.4151,
      "upper": 426.5879,
      "position": "中間"
    },
    "rsi_short": 22.31,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.71
    }
  }
}

{
  "close": 386.43,
  "volume": 892700,
  "changePercent": 1.25
}